Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations-Reference-Cited by-同舟云学术

Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations

Published:2018-06-22 Issue:2 Volume:123 Page:284-292
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Bancroft Elizabeth K.¹²^ORCID,Saya Sibel¹²,Page Elizabeth C.¹²,Myhill Kathryn¹²,Thomas Sarah¹²,Pope Jennifer¹²,Chamberlain Anthony¹²,Hart Rachel³,Glover Wayne³,Cook Jackie⁴,Rosario Derek J.⁵,Helfand Brian T.⁶,Hutten Selkirk Christina⁶,Davidson Rosemarie⁷,Longmuir Mark⁷,Eccles Diana M.⁸⁹,Gadea Neus¹⁰,Brewer Carole¹¹,Barwell Julian¹²¹³,Salinas Monica¹⁴,Greenhalgh Lynn¹⁵,Tischkowitz Marc¹⁶,Henderson Alex¹⁷,Evans David Gareth¹⁸,Buys Saundra S.¹⁹,Eeles Rosalind A.¹²,Aaronson Neil K.²⁰, ,

Affiliation:

1. Oncogenetics Team; Royal Marsden NHS Foundation Trust; London UK

2. Oncogenetics Team; Institute of Cancer Research; London UK

3. Clinical Genetics Unit; Birmingham Women's Hospital; Birmingham UK

4. Sheffield Clinical Genetics Service; Sheffield Children's Hospital; Sheffield UK

5. Department of Urology; Royal Hallamshire Hospital; Sheffield UK

6. John and Carol Walter Center for Urological Health; NorthShore University HealthSystem; Evanston IL USA

7. Clinical Genetics Department; Queen Elizabeth University Hospital; Glasgow UK

8. Wessex Clinical Genetics Service; Princess Anne Hospital; Southampton UK

9. Faculty of Medicine; University of Southampton; University Hospital Southampton NHS Foundation Trust; Southampton UK

10. High Risk and Cancer Prevention Clinic; Vall d'Hebron University Hospital; Barcelona Spain

11. Clinical Genetics Department; Royal Devon and Exeter Hospital; Exeter UK

12. Department of Genetics; University of Leicester; Leicester UK

13. Clinical Genetics; University Hospitals Leicester; Leicester UK

14. Hereditary Cancer Programme; Catalan Institute of Oncology (ICO-IDIBELL, CIBERONC); L'Hospitalet de Llobregat; Barcelona Spain

15. Cheshire and Mersey Clinical Genetics Service; Liverpool Women's Hospital; Liverpool UK

16. Academic Department of Medical Genetics; University of Cambridge; Cambridge UK

17. Northern Genetics Service; Newcastle upon Tyne Hospitals; Newcastle UK

18. Manchester Centre for Genomic Medicine; Central Manchester University Hospitals NHS Foundation Trust; Manchester UK

19. Huntsman Cancer Institute; University of Utah Health; Salt Lake City UT USA

20. Division of Psychosocial Research and Epidemiology; Netherlands Cancer Institute; Amsterdam The Netherlands

Funder

Cancer Research UK

Ronald and Rita McAulay Foundation

National Institute for Health Research

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14412/fullpdf

Reference47 articles.

1. Globocan Cancer Fact Sheets http://globocan.iarc.fr/old/FactSheets/cancers/prostate-new.asp

2. Germline BRCA1 mutations increase prostate cancer risk;Leongamornlert;Br J Cancer,2012

3. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients;Kote-Jarai;Br J Cancer,2011

4. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer;Castro;J Clin Oncol,2013

5. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer;Gallagher;Clin Cancer Res,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers;BJU International;2024-06-05

2. Links between gender norms and the intergenerational transmission of health information in parents carrying BRCA1/2 pathogenic variants;Journal of Genetic Counseling;2023-06-06

3. Initial outcomes and insights from a novel high‐risk prostate cancer screening clinic;The Prostate;2022-10-07

4. Helping Patients Understand and Cope with BRCA Mutations;Current Oncology Reports;2022-03-18

5. Psychological distress among patients awaiting histopathologic results after prostate biopsy: An unaddressed concern;Urologia Journal;2021-10-06